Pfizer Global Medical Grants Addressing Knowledge Gaps in Aplastic Anemia RFP
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: Friday 5th, August 2022
External Deadline: Wednesday 10th, August 2022
Description
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
Specific Area of Interest: Projects that will be considered for support will focus on improving the care of patients by addressing knowledge gaps in following areas:
- – early identification and diagnosis of aplastic anemia (AA) patients
- – awareness of AA in order to faster refer patients to higher clinical centers of reference
- – current standards for the treatment of AA and its complications
– clinical management of special patient subpopulations and difficult cases of AA patients
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Jessica Romano, Grant Officer (jessica.romano@pfizer.com).
Link to full RFP: Addressing Knowledge Gaps in Aplastic Anemia
Application Due Date: August 10, 2022